Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Cervical-vaginal disease in HIV immunosuppressed patients: management and present screening programme
1Department Obstetrics and Gynaecology, Department of Surgery Science, University of L'Aquila, Italy
2AIED Gynaecologist Consultant, Italy
3Department of Infectious Diseases, L'Aquila Regional Hospital, Italy
4Department of Anatomopathology, L'Aquila Regional Hospital, Italy
*Corresponding Author(s): L. Di Stefano E-mail:
The aim of this study was to evaluate the rate of the cervical intraepithelial neoplasia (L-SIL and H-SIL) in HIV-positive patients using cytological, colposcopic and histological examinations. The correlations between these cervical lesions, the role of HPV and the clinical and immunological aspects of HIV infection and inflammatory cervical-vaginal disease were studied. We believe that HPV infection and preneoplastic and/or neoplastic lesions occur more often in immunodepressed HIV-positive patients, and that on the grounds of the high risk of precancerous lesions in this population and the low sensibility of the Pap test, it is advisable to perform a colposcopic examination to discover early lesions that must undergo a specific biopsy.
Colposcopic examination; Pap test; HIV infection; HPV infection; Cervical-vaginal disease; Immunological state
L. Di Stefano,G. Coppola,S. Moro,E. Colageo,A. Cellini,G. Coletti. Cervical-vaginal disease in HIV immunosuppressed patients: management and present screening programme. European Journal of Gynaecological Oncology. 2006. 27(3);267-270.
[1] Agarossi A. et al.: "HIV e gestione dell'esame colposcopico" Reports of XV I SICPCV National Congress, 2001, 55.
[2] Ippolito G., Orchin N. et al.: "Epidemiology of the HIV/AIDS in the World". Masson, 2004, 9.
[3] Conti M. et al.: "HPV, HIV infection and risk of cervical intraepithelial neoplasia in former intravenous drug abusers". Gynaecol. Oneal., 1993, 49, 344.
[4] Wright T. et al.: "Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears". New York Cervical Disease Study. Ohstet. Gynaecol., 1994, 94, 591.
[5] Sopracordevole F. et al.: "Management of the preneoplastlc lesions of the lower urogenital tract in HIV positive patients". Ital. J. Ohstet. Gynecol., 2001, 231.
[6] McBell et al.: "HPV infection and immunological reaction". Gynecol. Oneal., 2000, 315.
[7] Monsonego J. et al.: "HPV infection and immunological reaction". Genital infect. and neoplastic pathology. Mediacom Editor I, 1, 5.
[8] Del Mistro A. et al.: "2HPV related neoplasias in HIV infected individuals". Eur. J. Cancer, 2001, 37, 1227.
[9] Brandbeer C. et al.: "Is infection with HIV a risk factor for cerv1-cal intraepithelial neoplasia?". Lancet, 1987, 1277.
[10] Wright T.C. et al.: "Human papillomavirus infection in HIV positive women and in HIV negative women: prevalence association with intraepithelial neoplasia, and impact of CD4+ count". 9" International Conference on AIDS/4" ST D World Congress, Berlin, June, 1993, 6.
[11] Ferenczy A. et al.: "Human papillomavirus and HIV co-infection and the risk of neoplasias of the lower genital tract: a review of recent developments". CMAJ, 2003, 169, 1500.
[12] Ellerbrock T.V. et al.: "Incidence of cervical squamous intraepithelial lesions in HIV infected women". JAMA, 2000, 283, 1031.
Top